Routine prolonged anticoagulation, for up to 48 hours after primary percutaneous coronary intervention (PCI) for patients presenting with ST-segment elevation myocardial infarction (STEMI), is safe but does not provide an ischemic benefit at 30 days post-procedure, new randomized trial results show.